PURPOSE OF REVIEW: Given the enormous impact congenital heart disease has on child health, it is imperative that we improve our understanding of the disease mechanisms that underlie patient phenotypes and clinical outcomes. This review will outline the merits of using the frog model, Xenopus, as a tool to study human cardiac development and left-right patterning mechanisms associated with congenital heart disease. RECENT FINDINGS: Patient-driven gene discovery continues to provide new insight into the mechanisms of congenital heart disease, and by extension, patient phenotypes and outcomes. By identifying gene variants in CHD patients, studies in Xenopus have elucidated the molecular mechanisms of how these candidate genes affect cardiac development, both cardiogenesis as well as left-right patterning, which can have a major impact on cardiac morphogenesis. Xenopus has also proved to be a useful screening tool for the biological relevance of identified patient-mutations, and ongoing investigations continue to illuminate disease mechanisms. SUMMARY: Analyses in model organisms can help to elucidate the disease mechanisms underlying CHD patient phenotypes. Using Xenopus to disentangle the genotype-phenotype relationships of well-known and novel disease genes could enhance the ability of physicians to efficaciously treat patients and predict clinical outcomes, ultimately improving quality of life and survival rates of patients born with congenital heart disease.
PURPOSE OF REVIEW: Given the enormous impact congenital heart disease has on child health, it is imperative that we improve our understanding of the disease mechanisms that underlie patient phenotypes and clinical outcomes. This review will outline the merits of using the frog model, Xenopus, as a tool to study human cardiac development and left-right patterning mechanisms associated with congenital heart disease. RECENT FINDINGS:Patient-driven gene discovery continues to provide new insight into the mechanisms of congenital heart disease, and by extension, patient phenotypes and outcomes. By identifying gene variants in CHD patients, studies in Xenopus have elucidated the molecular mechanisms of how these candidate genes affect cardiac development, both cardiogenesis as well as left-right patterning, which can have a major impact on cardiac morphogenesis. Xenopus has also proved to be a useful screening tool for the biological relevance of identified patient-mutations, and ongoing investigations continue to illuminate disease mechanisms. SUMMARY: Analyses in model organisms can help to elucidate the disease mechanisms underlying CHD patient phenotypes. Using Xenopus to disentangle the genotype-phenotype relationships of well-known and novel disease genes could enhance the ability of physicians to efficaciously treat patients and predict clinical outcomes, ultimately improving quality of life and survival rates of patients born with congenital heart disease.
Authors: Jason Homsy; Samir Zaidi; Yufeng Shen; James S Ware; Kaitlin E Samocha; Konrad J Karczewski; Steven R DePalma; David McKean; Hiroko Wakimoto; Josh Gorham; Sheng Chih Jin; John Deanfield; Alessandro Giardini; George A Porter; Richard Kim; Kaya Bilguvar; Francesc López-Giráldez; Irina Tikhonova; Shrikant Mane; Angela Romano-Adesman; Hongjian Qi; Badri Vardarajan; Lijiang Ma; Mark Daly; Amy E Roberts; Mark W Russell; Seema Mital; Jane W Newburger; J William Gaynor; Roger E Breitbart; Ivan Iossifov; Michael Ronemus; Stephan J Sanders; Jonathan R Kaltman; Jonathan G Seidman; Martina Brueckner; Bruce D Gelb; Elizabeth Goldmuntz; Richard P Lifton; Christine E Seidman; Wendy K Chung Journal: Science Date: 2015-12-04 Impact factor: 47.728
Authors: Florencia Del Viso; Fang Huang; Jordan Myers; Madeleine Chalfant; Yongdeng Zhang; Nooreen Reza; Joerg Bewersdorf; C Patrick Lusk; Mustafa K Khokha Journal: Dev Cell Date: 2016-09-01 Impact factor: 12.270
Authors: Erin Kaltenbrun; Panna Tandon; Nirav M Amin; Lauren Waldron; Chris Showell; Frank L Conlon Journal: Birth Defects Res A Clin Mol Teratol Date: 2011-04-28
Authors: Paul D Grossfeld; Teresa Mattina; Zona Lai; Remi Favier; Ken Lyons Jones; Finbarr Cotter; Christopher Jones Journal: Am J Med Genet A Date: 2004-08-15 Impact factor: 2.802
Authors: L A Penny; M Dell'Aquila; M C Jones; J Bergoffen; C Cunniff; J P Fryns; E Grace; J M Graham; B Kousseff; T Mattina Journal: Am J Hum Genet Date: 1995-03 Impact factor: 11.025
Authors: Kiran Musunuru; Daniel Bernstein; F Sessions Cole; Mustafa K Khokha; Frank S Lee; Shin Lin; Thomas V McDonald; Ivan P Moskowitz; Thomas Quertermous; Vijay G Sankaran; David A Schwartz; Edwin K Silverman; Xiaobo Zhou; Ahmed A K Hasan; Xiao-Zhong James Luo Journal: Circ Genom Precis Med Date: 2018-04
Authors: Sara Brin Rosenthal; Helen Rankin Willsey; Yuxiao Xu; Yuan Mei; Jeanselle Dea; Sheng Wang; Charlotte Curtis; Emily Sempou; Mustafa K Khokha; Neil C Chi; Arthur Jeremy Willsey; Kathleen M Fisch; Trey Ideker Journal: Cell Syst Date: 2021-08-18 Impact factor: 10.304
Authors: Helen Rankin Willsey; Cameron R T Exner; Yuxiao Xu; Amanda Everitt; Nawei Sun; Belinda Wang; Jeanselle Dea; Galina Schmunk; Yefim Zaltsman; Nia Teerikorpi; Albert Kim; Aoife S Anderson; David Shin; Meghan Seyler; Tomasz J Nowakowski; Richard M Harland; A Jeremy Willsey; Matthew W State Journal: Neuron Date: 2021-01-25 Impact factor: 18.688
Authors: Mardi J Nenni; Malcolm E Fisher; Christina James-Zorn; Troy J Pells; Virgilio Ponferrada; Stanley Chu; Joshua D Fortriede; Kevin A Burns; Ying Wang; Vaneet S Lotay; Dong Zhou Wang; Erik Segerdell; Praneet Chaturvedi; Kamran Karimi; Peter D Vize; Aaron M Zorn Journal: Front Physiol Date: 2019-02-26 Impact factor: 4.566
Authors: Joel D Federspiel; Panna Tandon; Caralynn M Wilczewski; Lauren Wasson; Laura E Herring; Samvida S Venkatesh; Ileana M Cristea; Frank L Conlon Journal: PLoS Biol Date: 2019-09-06 Impact factor: 8.029